Skip to main content

Dr Francesca Querques


Biochemistry, Cell and Systems Biology
Part of
Institute of Systems, Molecular & Integrative Biology
Faculty of Health and Life Sciences

Contact

F.Querques@liverpool.ac.uk

Publications

What type of publication do you want to show?

2023

Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.c.6545790.v2

DOI
10.1158/1541-7786.c.6545790.v2
Other

Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.c.6545790

DOI
10.1158/1541-7786.c.6545790
Other

Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725161

DOI
10.1158/1541-7786.22725161
Other

Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725161.v1

DOI
10.1158/1541-7786.22725161.v1
Other

Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725158

DOI
10.1158/1541-7786.22725158
Other

Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725158.v1

DOI
10.1158/1541-7786.22725158.v1
Other

Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725155.v1

DOI
10.1158/1541-7786.22725155.v1
Other

Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725155

DOI
10.1158/1541-7786.22725155
Other

Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725152.v1

DOI
10.1158/1541-7786.22725152.v1
Other

Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725152

DOI
10.1158/1541-7786.22725152
Other

Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725149.v1

DOI
10.1158/1541-7786.22725149.v1
Other

Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725149

DOI
10.1158/1541-7786.22725149
Other

Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725146.v1

DOI
10.1158/1541-7786.22725146.v1
Other

Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725146

DOI
10.1158/1541-7786.22725146
Other

Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725143

DOI
10.1158/1541-7786.22725143
Other

Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22725143.v1

DOI
10.1158/1541-7786.22725143.v1
Other

Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Data from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.c.6545790.v1

DOI
10.1158/1541-7786.c.6545790.v1
Other

Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528794.v1

DOI
10.1158/1541-7786.22528794.v1
Other

Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Figures S1 to S16 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528794

DOI
10.1158/1541-7786.22528794
Other

Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528791

DOI
10.1158/1541-7786.22528791
Other

Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Methods and References from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528791.v1

DOI
10.1158/1541-7786.22528791.v1
Other

Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528788

DOI
10.1158/1541-7786.22528788
Other

Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S1 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528788.v1

DOI
10.1158/1541-7786.22528788.v1
Other

Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528785

DOI
10.1158/1541-7786.22528785
Other

Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S2 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528785.v1

DOI
10.1158/1541-7786.22528785.v1
Other

Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528779

DOI
10.1158/1541-7786.22528779
Other

Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S3 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528779.v1

DOI
10.1158/1541-7786.22528779.v1
Other

Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528776

DOI
10.1158/1541-7786.22528776
Other

Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S4 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528776.v1

DOI
10.1158/1541-7786.22528776.v1
Other

Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528773

DOI
10.1158/1541-7786.22528773
Other

Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification

Barnett, S. E., Kenyani, J., Tripari, M., Butt, Z., Grosman, R., Querques, F., . . . Coulson, J. M. (2023). Supplementary Table S5 from BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. doi:10.1158/1541-7786.22528773.v1

DOI
10.1158/1541-7786.22528773.v1
Other

2021

2019

Identification of a Novel Transcription Factor Required for Osteogenic Differentiation of Mesenchymal Stem Cells

Querques, F., D'Agostino, A., Cozzolino, C., Cozzuto, L., Lombardo, B., Leggiero, E., . . . Pastore, L. (2019). Identification of a Novel Transcription Factor Required for Osteogenic Differentiation of Mesenchymal Stem Cells. STEM CELLS AND DEVELOPMENT, 28(6), 370-383. doi:10.1089/scd.2018.0152

DOI
10.1089/scd.2018.0152
Journal article

2015

Angiotensin Receptor I Stimulates Osteoprogenitor Proliferation Through TGFβ-Mediated Signaling

Querques, F., Cantilena, B., Cozzolino, C., Esposito, M. T., Passaro, F., Parisi, S., . . . Pastore, L. (2015). Angiotensin Receptor I Stimulates Osteoprogenitor Proliferation Through TGFβ-Mediated Signaling. JOURNAL OF CELLULAR PHYSIOLOGY, 230(7), 1466-1474. doi:10.1002/jcp.24887

DOI
10.1002/jcp.24887
Journal article

2014

Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells

Di Fiore, R., Marcatti, M., Drago-Ferrante, R., D'Anneo, A., Giuliano, M., Carlisi, D., . . . Vento, R. (2014). Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells. BONE, 60, 198-212. doi:10.1016/j.bone.2013.12.021

DOI
10.1016/j.bone.2013.12.021
Journal article

Helper Dependent-Adenoviral Vector Expressing Transferrin-LDL Receptor Fusion Protein for Gene Therapy of Familial Hypercholesterolemia

Leggiero, E., Ranieri, R., Lombardo, B., Iaffaldano, L., Querques, F., Salvatore, F., & Pastore, L. (2014). Helper Dependent-Adenoviral Vector Expressing Transferrin-LDL Receptor Fusion Protein for Gene Therapy of Familial Hypercholesterolemia. In MOLECULAR THERAPY Vol. 22 (pp. S143). Retrieved from https://www.webofscience.com/

Conference Paper